[MRI in mucoviscidosis (cystic fibrosis)].
Cystic fibrosis (CF) is a multi-systemic disease with major impact on the lungs. Pulmonary manifestation is crucial for the prognosis and life expectancy of patients. Imaging modalities and lung function tests reflect the pulmonary status in these patients. The standard imaging modality for diagnosis and follow-up of pulmonary changes is chest x-ray. The gold standard for the detection of parenchymal lung changes remains high resolution computed tomography (HRCT), but this is not used routinely for CF-patients due to radiation exposure. Magnetic resonance imaging (MRI) used to be of no importance in monitoring cystic fibrosis lung disease, as shown in studies from the 1980s and early 1990 s. The continuing improvement of MRI techniques, however, has allowed for an adequate application of this non-radiation method in diagnosing the major pulmonary findings in CF, in addition to the assessment of lung function.
Eichinger
M
M
Abteilung Radiologie, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg. m.eichinger@dkfz.de
Puderbach
M
M
Heussel
C-P
CP
Kauczor
H-U
HU
D003550:Cystic Fibrosis / Q000175:diagnosis*; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D021621:Imaging, Three-Dimensional / Q000639:trends*; D008168:Lung / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000639:trends*; D011658:Pulmonary Fibrosis / Q000175:diagnosis*